1
|
Stefani G, Kouvata E, Vassilopoulos G. Light-Chain Amyloidosis: The Great Impostor. Life (Basel) 2023; 14:42. [PMID: 38255657 PMCID: PMC10817319 DOI: 10.3390/life14010042] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/27/2023] [Revised: 11/28/2023] [Accepted: 12/24/2023] [Indexed: 01/24/2024] Open
Abstract
Light-chain amyloidosis (AL) is a disease of protean manifestations due to a wide spectrum of organs that can be affected. The disorder is caused by the deposition of an extracellular amorphous material, the amyloid, which is produced by malignant plasma cells. The latter usually reside in the bone marrow; plasma cell infiltration is often low, in sharp contrast to what we observe in multiple myeloma. The disease may run below the physician's radar for a while before clinical suspicion is raised and targeted tests are performed. In this short review, we try to answer most of the questions that a practicing physician may ask in a relative clinical setting. The text is formed as a series of reader-friendly questions that cover the subject of AL amyloidosis from history to current therapy.
Collapse
Affiliation(s)
- Georgia Stefani
- Department of Hematology, Larisa University Hospital, 41110 Larisa, Greece; (G.S.); (G.V.)
| | - Evangelia Kouvata
- Department of Hematology, Larisa University Hospital, 41110 Larisa, Greece; (G.S.); (G.V.)
| | - George Vassilopoulos
- Department of Hematology, Larisa University Hospital, 41110 Larisa, Greece; (G.S.); (G.V.)
- Cell and Gene Therapy Lab, Biomedical Research Foundation of the Academy of Athens, 11527 Athens, Greece
| |
Collapse
|
2
|
Gospodinova M, Zhelyazkova S, Chamova T, Asenov O, Pavlova Z, Todorov T, Mikova D, Palashev Y, Gruev I, Kundurdjiev A, Todorova A, Tournev I. Case Report: Transthyretin Glu54Leu-a rare mutation with predominant cardiac phenotype. Front Cardiovasc Med 2023; 10:1228410. [PMID: 38028480 PMCID: PMC10644754 DOI: 10.3389/fcvm.2023.1228410] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/24/2023] [Accepted: 10/05/2023] [Indexed: 12/01/2023] Open
Abstract
We report two unrelated Bulgarian families with hereditary transthyretin (ATTR) amyloidosis due to a rare p.Glu74Leu (Glu54Leu) pathogenic variant found in seven individuals-three of them symptomatic. Only one family with the same variant and with a Swedish origin has been clinically described so far. Our patients are characterized by predominant cardiac involvement, very much similar to the Swedish patients. Although the initial complaint was bilateral carpal tunnel syndrome, advanced amyloid cardiomyopathy was found in two symptomatic carriers at diagnosis with heart failure manifestations. The neurological involvement was considered as mild, with mainly sensory signs and symptoms being present. We followed a non-biopsy algorithm to confirm the diagnosis. Tafamidis 61 mg has been initiated as the only approved disease modifying treatment for ATTR cardiomyopathy. Clinical stability in the absence of adverse events has been observed at follow up.
Collapse
Affiliation(s)
- Mariana Gospodinova
- Expert Centre for ATTR Cardiac Amyloidosis, St Ivan Rilski University Hospital, Sofia, Bulgaria
| | - Sashka Zhelyazkova
- Clinic of Neurology, Aleksandrovska University Hospital, Medical University, Sofia, Bulgaria
| | - Teodora Chamova
- Clinic of Neurology, Aleksandrovska University Hospital, Medical University, Sofia, Bulgaria
| | - Ognyan Asenov
- Clinic of Neurology, Aleksandrovska University Hospital, Medical University, Sofia, Bulgaria
| | | | - Tihomir Todorov
- Genetic Medico-Diagnostic Laboratory “Genica”, Sofia, Bulgaria
| | - Dilyana Mikova
- Department of Nuclear Medicine, St Ivan Rilski University Hospital, Sofia, Bulgaria
| | - Yordan Palashev
- Department of Nuclear Medicine, St Ivan Rilski University Hospital, Sofia, Bulgaria
- Clinical Center of Nuclear Medicine and Radiology, Medical University, Sofia, Bulgaria
| | - Ivan Gruev
- National Multi-profile Transport Hospital“Tsar Boris III”, Sofia, Bulgaria
| | - Atanas Kundurdjiev
- Expert Centre for ATTR Cardiac Amyloidosis, St Ivan Rilski University Hospital, Sofia, Bulgaria
- Clinic of Nephrology, St Ivan Rilski University Hospital, Sofia, Bulgaria
| | - Albena Todorova
- Genetic Medico-Diagnostic Laboratory “Genica”, Sofia, Bulgaria
- Department of Medical Chemistry and Biochemistry, Medical University Sofia, Sofia, Bulgaria
| | - Ivailo Tournev
- Clinic of Neurology, Aleksandrovska University Hospital, Medical University, Sofia, Bulgaria
- Department of Cognitive Science and Psychology, New Bulgarian University, Sofia, Bulgaria
| |
Collapse
|